<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072717</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY02000782</org_study_id>
    <nct_id>NCT05072717</nct_id>
  </id_info>
  <brief_title>Dynamic Contrast-enhanced Fluorescence Arthroscopy of Meniscus Pilot</brief_title>
  <official_title>Single-center Pilot Prospective Observational Study to Determine Feasibility of Assessing Meniscal Tissue Vascularity Using Dynamic Contrast-enhanced Fluorescence Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KARL STORZ Endoscopy-America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center pilot prospective observational study to determine feasibility of assessing&#xD;
      meniscal tissue vascularity using dynamic contrast-enhanced fluorescence arthroscopy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this pilot study is to determine whether it is possible to translate the&#xD;
      dynamic contrast-enhanced fluorescence imaging methods we have been using to assess bone&#xD;
      perfusion in orthopaedic trauma patients to the field of arthroscopic surgery. In other&#xD;
      words, it is the development of dynamic contrast-enhanced fluorescence arthroscopy.&#xD;
&#xD;
      While fluorescence arthroscopes are available, there are several challenges associated with&#xD;
      minimally invasive procedures compared with wide field imaging, and this pilot study will&#xD;
      help determine whether these can be overcome. They are mainly to do with motion artifacts&#xD;
      caused by the non-fixed position of the scope during wash-in/wash-out of the dye, and the use&#xD;
      of an arthroscopic pump to pressurize the fluid in the surgical cavity.&#xD;
&#xD;
      The long-term goal of this work is to use dynamic contrast-enhanced fluorescence arthroscopy&#xD;
      for the assessment of vascularity of meniscal tissue arthroscopically to determine potential&#xD;
      healing capacity using dynamic contrast-enhanced fluorescence imaging.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of meniscal blood supply using Indocyanine green (ICG)</measure>
    <time_frame>Baseline, up to 20 minutes</time_frame>
    <description>The primary study outcome is to measure meniscal blood flow in patients during surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pressure setting (mm Hg) required for optimal visualization of ICG-based fluorescence.</measure>
    <time_frame>Baseline, up to 20 minutes</time_frame>
    <description>assess the impact of arthroscopic pump pressure on the visualization of ICG-based dynamic contrast-enhanced fluorescence in the joint and to develop parameters around effect of the pump.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>Patients with a meniscal tear requiring surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be administered Food and Drug Administration (FDA) approved Indocyanine green (ICG) through intravenous injection and imaged by a FDA approved surgical fluorescence imaging device. Both ICG fluorescence and the imaging system have been used for routine clinical practice for many years. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to meniscal perfusion can be captured by an arthroscopic imaging system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Perfusion with Indocyanine green</intervention_name>
    <description>Infusion of Indocyanine green to determine perfusion in meniscal tear tissue.</description>
    <arm_group_label>Patients with a meniscal tear requiring surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients 18 years of age or older.&#xD;
&#xD;
          2. Meniscal tear based on MRI or preoperative assessment&#xD;
&#xD;
          3. Provision of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability of patient to provide informed consent&#xD;
&#xD;
          2. Iodine allergy.&#xD;
&#xD;
          3. Evidence of septic arthritis of the proposed surgical joint.&#xD;
&#xD;
          4. Burns.&#xD;
&#xD;
          5. Incarceration.&#xD;
&#xD;
          6. Expected survival of less than 90 days.&#xD;
&#xD;
          7. Problems, in the judgment of study personnel, with maintaining follow-up with the&#xD;
             patient.&#xD;
&#xD;
          8. Pregnant or Breastfeeding Women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael B Sparks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael B Sparks, MD</last_name>
    <phone>1-603-65</phone>
    <email>michael.b.sparks@hitchcock.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy E Hall, MS</last_name>
    <phone>603-653-3306</phone>
    <email>amy.e.hall@hitchcock.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Michael B Sparks, MD</last_name>
      <phone>603-650-5133</phone>
      <email>michael.b.sparks@hitchcock.org</email>
    </contact>
    <contact_backup>
      <last_name>Amy E Hall, MS</last_name>
      <phone>603-653-3306</phone>
      <email>amy.e.hall@hitchcock.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Liao D, Xie L, Han Y, Du S, Wang H, Zeng C, Li Y. Dynamic contrast-enhanced magnetic resonance imaging for differentiating osteomyelitis from acute neuropathic arthropathy in the complicated diabetic foot. Skeletal Radiol. 2018 Oct;47(10):1337-1347. doi: 10.1007/s00256-018-2942-4. Epub 2018 Apr 13.</citation>
    <PMID>29654348</PMID>
  </reference>
  <reference>
    <citation>Fischer C, Nissen M, Schmidmaier G, Bruckner T, Kauczor HU, Weber MA. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for the prediction of non-union consolidation. Injury. 2017 Feb;48(2):357-363. doi: 10.1016/j.injury.2017.01.021. Epub 2017 Jan 9.</citation>
    <PMID>28088373</PMID>
  </reference>
  <reference>
    <citation>Fischer C, Preuss EM, Tanner M, Bruckner T, Krix M, Amarteifio E, Miska M, Moghaddam-Alvandi A, Schmidmaier G, Weber MA. Dynamic Contrast-Enhanced Sonography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Preoperative Diagnosis of Infected Nonunions. J Ultrasound Med. 2016 May;35(5):933-42. doi: 10.7863/ultra.15.06107. Epub 2016 Apr 1.</citation>
    <PMID>27036169</PMID>
  </reference>
  <reference>
    <citation>Müller G, Månsson S, Müller MF, Johansson M, Björkman A. Increased perfusion in dynamic gadolinium-enhanced MRI correlates with areas of bone repair and of bone necrosis in patients with Kienböck's disease. J Magn Reson Imaging. 2019 Aug;50(2):481-489. doi: 10.1002/jmri.26573. Epub 2018 Dec 16.</citation>
    <PMID>30556360</PMID>
  </reference>
  <reference>
    <citation>Schoierer O, Bloess K, Bender D, Burkholder I, Kauczor HU, Schmidmaier G, Weber MA. Dynamic contrast-enhanced magnetic resonance imaging can assess vascularity within fracture non-unions and predicts good outcome. Eur Radiol. 2014 Feb;24(2):449-59. doi: 10.1007/s00330-013-3043-3. Epub 2013 Oct 22.</citation>
    <PMID>24145951</PMID>
  </reference>
  <reference>
    <citation>Martín Noguerol T, Luna Alcalá A, Beltrán LS, Gómez Cabrera M, Broncano Cabrero J, Vilanova JC. Advanced MR Imaging Techniques for Differentiation of Neuropathic Arthropathy and Osteomyelitis in the Diabetic Foot. Radiographics. 2017 Jul-Aug;37(4):1161-1180. doi: 10.1148/rg.2017160101. Review.</citation>
    <PMID>28696850</PMID>
  </reference>
  <reference>
    <citation>Cahill RA, Ris F, Mortensen NJ. Near-infrared laparoscopy for real-time intra-operative arterial and lymphatic perfusion imaging. Colorectal Dis. 2011 Nov;13 Suppl 7:12-7. doi: 10.1111/j.1463-1318.2011.02772.x.</citation>
    <PMID>22098511</PMID>
  </reference>
  <reference>
    <citation>Reinhart MB, Huntington CR, Blair LJ, Heniford BT, Augenstein VA. Indocyanine Green: Historical Context, Current Applications, and Future Considerations. Surg Innov. 2016 Apr;23(2):166-75. doi: 10.1177/1553350615604053. Epub 2015 Sep 10. Review.</citation>
    <PMID>26359355</PMID>
  </reference>
  <reference>
    <citation>Valerio I, Green JM 3rd, Sacks JM, Thomas S, Sabino J, Acarturk TO. Vascularized osseous flaps and assessing their bipartate perfusion pattern via intraoperative fluorescence angiography. J Reconstr Microsurg. 2015 Jan;31(1):45-53. doi: 10.1055/s-0034-1383821. Epub 2014 Dec 3.</citation>
    <PMID>25469765</PMID>
  </reference>
  <reference>
    <citation>Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, Venermo M, Välisuo P. A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging. 2012;2012:940585. doi: 10.1155/2012/940585. Epub 2012 Apr 22.</citation>
    <PMID>22577366</PMID>
  </reference>
  <reference>
    <citation>Boni L, David G, Mangano A, Dionigi G, Rausei S, Spampatti S, Cassinotti E, Fingerhut A. Clinical applications of indocyanine green (ICG) enhanced fluorescence in laparoscopic surgery. Surg Endosc. 2015 Jul;29(7):2046-55. doi: 10.1007/s00464-014-3895-x. Epub 2014 Oct 11.</citation>
    <PMID>25303914</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Michael B. Sparks</investigator_full_name>
    <investigator_title>Associate Professor of Orthopaedics</investigator_title>
  </responsible_party>
  <keyword>meniscus</keyword>
  <keyword>Indocyanine green</keyword>
  <keyword>fluorescence</keyword>
  <keyword>imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

